1.Chernyaeva E., Rotkevich M., Krasheninnikova K., Yurchenko A., Vyazovaya A., Mokrousov I, et al. Whole-genome analysis of mycobacterium tuberculosis from patients with tuberculous spondylitis, Russia. Emerg Infect Dis. 2018. 24:579–83.
2.Turner RD., Chiu C., Churchyard GJ., Esmail H., Lewinsohn DM., Gandhi NR, et al. Tuberculosis infectiousness and host susceptibility. J Infect Dis. 2017. 216(suppl_6):S636–43.
Article
3.Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990. 335:387–90.
Article
4.Chandrasekaran P., Saravanan N., Bethunaickan R., Tripathy S. Malnutrition: modulator of immune responses in tuberculosis. Front Immunol. 2017. 8:1316.
Article
5.Cantwell MF., McKenna MT., McCray E., Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998. 157:1016–20.
6.Figueiredo AA., Lucon AM. Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol. 2008. 10:207–17.
7.Qi H., Sun L., Jin YQ., Shen C., Chu P., Wang SF, et al. rs2243268 and rs2243274 of interleukin-4 (IL-4) gene are associated with reduced risk for extrapulmonary and severe tuberculosis in Chinese Han children. Infect Genet Evol. 2014. 23:121–8.
Article
8.Sivangala R., Ponnana M., Thada S., Joshi L., Ansari S., Hussain H, et al. Association of cytokine gene polymorphisms in patients with tuberculosis and their household contacts. Scand J Immunol. 2014. 79:197–205.
Article
9.Chatterjee S., Talaat KR., van Seventer EE., Feng CG., Scott AL., Jedlicka A, et al. Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages. PLoS One. 2017. 12:e0179701.
Article
10.Song J., Park H., Lee G. Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml. Biochem Genet. 2013. 51:264–74.
11.Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015. 78:47–55.
Article
12.Peto HM., Pratt RH., Harrington TA., LoBue PA., Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009. 49:1350–7.
Article
13.Pehme L., Hollo V., Rahu M., Altraja A. Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations. Chest. 2005. 127:1289–95.
Article
14.Wangoo A., Sparer T., Brown IN., Snewin VA., Janssen R., Thole J, et al. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol. 2001. 166:3432–9.
Article
15.Cantwell MF., Snider DE Jr., Cauthen GM., Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994. 272:535–9.
Article